TRENDING :  Market Movers  |  Top 50   SPY (-0.03%)    UNP (1.12%)    UGAZ (2.26%)    TYME (-3.29%)    RYAAY (-2.05%)    PANW (0.95%)    PAGS (-0.44%)    ORCL (-0.15%)    MU (-1.41%)    MJ (1.73%)    MHK (0.19%)    M (-2.84%)    IWM (-0.17%)    GOOGL (-0.02%)    GDXJ (-0.32%)    FIS (0.56%)    FB (0.86%)    EWZ (-0.6%)    EWW (-0.03%)    CRM (0.9%)    CGC (5.24%)    BABA (-0.95%)    BA (-0.52%)    ATVI (-0.71%)    ARCW (5.24%)

 DERM - Dermira

$11.12 [-0.44][-3.73%]

Next Earnings

5/2/2019

AMC

Recommend
Trade Idea »



ANALYST RATINGS

Quarterly Rating Chart
Rating

2


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $13.00
Low $13.00
Average $13.00
Current $11.12

CompanyAnalyst NamePT ActionActionRatingTargetDate
H.C. WainwrightAnnouncesInitiates Coverage OnBuy$13.0002/14/19
*Last 90 days

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $DERM

TRENDING ARTICLES



Here's Why Dermira Shot Up 62% in March

04/08/19
What happened Investors delighted with clinical trial results drove Dermira NASDAQ DERM stock 62 3 higher in March according to data from S amp P Global Market Intelligence A failed asthma candidate that Dermira bought less than two years ago could be worth a lot